Mendelian Disorders of High-Density Lipoprotein Metabolism

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Circulation Research

• Publication date

  2014-01-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/CIRCRESAHA.113.300634PMID 24385507
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Osbpl8 Deficiency in Mouse Causes an Elevation of High-Density Lipoproteins and Gender-Specific Alterations of Lipid Metabolism

  2013cited by this paper
• The Impact of Partial and Complete Loss-of-Function Mutations in Endothelial Lipase on High-Density Lipoprotein Levels and Functionality in Humans

  2013cited by this paper
• High density lipoprotein as a source of cholesterol for adrenal steroidogenesis: a study in individuals with low plasma HDL-C

  2013cited by this paper
• RNAi–Based Functional Profiling of Loci from Blood Lipid Genome-Wide Association Studies Identifies Genes with Cholesterol-Regulatory Function

  2013cited by this paper
• Evidence of a Polygenic Origin of Extreme High-Density Lipoprotein Cholesterol Levels

  2013cited by this paper
• News on the genetics of lipoprotein metabolism and cardiovascular disease.

  2013cited by this paper
• Modification of the lipidome in RAW264.7 macrophage subjected to stable silencing of oxysterol-binding proteins.

  2013cited by this paper
• Novel combined GPIHBP1 mutations in a patient with hypertriglyceridemia associated with CAD.

  2013influential reference
• High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease

  2013influential reference
• The Apolipoprotein M–Sphingosine-1-Phosphate Axis: Biological Relevance in Lipoprotein Metabolism, Lipid Disorders and Atherosclerosis

  2013cited by this paper
• HDL—is it too big to fail?

  2013cited by this paper
• Whole Genome Sequence-Based Analysis of a Model Complex Trait, High Density Lipoprotein Cholesterol

  2013cited by this paper
• Apolipoprotein C-II deficiency with no rare variant in the APOC2 gene.

  2013cited by this paper
• Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

  2012cited by this paper
• High density lipoprotein in patients with liver failure; relation to sepsis, adrenal function and outcome of illness

  2012cited by this paper
• Genetic variation in metabolic phenotypes: study designs and applications

  2012cited by this paper
• Faculty Opinions recommendation of Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression.

  2012cited by this paper
• Functions of scavenger receptor class B, type I in atherosclerosis

  2012cited by this paper
• Functional Characterization of Newly-Discovered Mutations in Human SR-BI

  2012cited by this paper
• LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.

  2012cited by this paper
• Genetics of atherosclerosis.

  2012cited by this paper
• A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease.

  2012influential reference
• Sphingosine 1-Phosphate (S1P) Carrier-dependent Regulation of Endothelial Barrier

  2012cited by this paper
• Unraveling the Regulatory Mechanisms Underlying Tissue-Dependent Genetic Variation of Gene Expression

  2012cited by this paper
• Exome Sequencing Identifies 2 Rare Variants for Low High-Density Lipoprotein Cholesterol in an Extended Family

  2012cited by this paper
• Functional Analysis of Two PLA2G2A Variants Associated with Secretory Phospholipase A2-IIA Levels

  2012cited by this paper
• The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis?

  2012cited by this paper
• Segregation of LIPG, CETP, and GALNT2 Mutations in Caucasian Families with Extremely High HDL Cholesterol

  2012cited by this paper
• LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals

  2012cited by this paper
• Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects.

  2012cited by this paper
• Genetic Variation in ABCG1 and Risk of Myocardial Infarction and Ischemic Heart Disease

  2012cited by this paper
• Excess of Rare Variants in Non–Genome-Wide Association Study Candidate Genes in Patients With Hypertriglyceridemia

  2012cited by this paper
• Apolipoprotein M Gene (APOM) Polymorphism Modifies Metabolic and Disease Traits in Type 2 Diabetes

  2011cited by this paper
• Cytoplasmic oxysterol-binding proteins: sterol sensors or transporters?

  2011cited by this paper
• Childhood‐onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation

  2011cited by this paper
• Inhibition of miR-33 a / b in non-human primates raises plasma HDL and lowers VLDL triglycerides

  2011cited by this paper
• Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism.

  2011cited by this paper
• Deletion of GPIHBP1 causing severe chylomicronemia

  2011cited by this paper
• Inhibition of miR-33a/b in non-human primates raises plasma HDL and reduces VLDL triglycerides

  2011cited by this paper
• A polymorphism in the ABCG1 promoter is functionally associated with coronary artery disease in a Chinese Han population.

  2011cited by this paper
• Genetic variant of the scavenger receptor BI in humans.

  2011cited by this paper
• GPIHBP1, an endothelial cell transporter for lipoprotein lipase

  2011cited by this paper
• Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans

  2011cited by this paper
• Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man.

  2011cited by this paper
• Glucuronic Acid Epimerase is Associated with Plasma Triglyceride and High‐Density Lipoprotein Cholesterol Levels in Turks

  2011cited by this paper
• APOC3 deficiency: from mice to man

  2010cited by this paper
• Thematic Review Series: Genetics of Human Lipid Diseases Genetic causes of high and low serum HDL-cholesterol

  2010cited by this paper
• Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia.

  2010cited by this paper
• Oxysterol-binding proteins.

  2010cited by this paper
• Increased Atherosclerosis in Mice With Vascular ATP-Binding Cassette Transporter G1 Deficiency—Brief Report

  2010cited by this paper
• Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice.

  2010cited by this paper
• Baseline and on-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy.

  2010cited by this paper
• Restoration of High-Density Lipoprotein Levels by Cholesteryl Ester Transfer Protein Expression in Scavenger Receptor Class B Type I (SR-BI) Knockout Mice Does Not Normalize Pathologies Associated With SR-BI Deficiency

  2010cited by this paper
• Association of selected ABC gene family single nucleotide polymorphisms with postprandial lipoproteins: results from the population-based Hortega study.

  2010cited by this paper
• Investigation of Variants Identified in Caucasian Genome-Wide Association Studies for Plasma High-Density Lipoprotein Cholesterol and Triglycerides Levels in Mexican Dyslipidemic Study Samples

  2010cited by this paper
• GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries.

  2010cited by this paper
• Abstract 17773: Patients with Low Plasma High Density Lipoprotein-Cholesterol due to Mutations in the Gene Encoding for Lecithin: Cholesterol Acyl Transferase have Increased Atherosclerosis: A 3.0 Tesla MRI Study.

  2010cited by this paper
• The diverse functions of oxysterol-binding proteins.

  2010cited by this paper
• Genetic Variation at the Phospholipid Transfer Protein Locus Affects Its Activity and High-Density Lipoprotein Size and Is a Novel Marker of Cardiovascular Disease Susceptibility

  2010cited by this paper
• Apolipoprotein M expression increases the size of nascent preβ HDL formed by ATP binding cassette transporter A1

  2010cited by this paper
• The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

  2010cited by this paper
• Major Lipids, Apolipoproteins, and Risk of Vascular Disease

  2010influential reference
• Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids

  2010influential reference
• Plasma triglyceride levels and body mass index values are the most important determinants of prebeta-1 HDL concentrations in patients with various types of primary dyslipidemia.

  2010cited by this paper
• Smoking intensity and lipoprotein abnormalities in active smokers.

  2009cited by this paper
• A naturally occurring variant of endothelial lipase associated with elevated HDL exhibits impaired synthesis[S]

  2009influential reference
• Marked high density lipoprotein deficiency due to apolipoprotein A-I Tomioka (codon 138 deletion).

  2009cited by this paper
• Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review.

  2009cited by this paper
• Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.

  2009cited by this paper
• Regulation of apoAI processing by procollagen C-proteinase enhancer-2 and bone morphogenetic protein-1 Published, JLR Papers in Press, February 23, 2009.

  2009cited by this paper
• The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes.

  2009cited by this paper
• Common variants at 30 loci contribute to polygenic dyslipidemia

  2009cited by this paper
• Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans.

  2009cited by this paper
• Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene.

  2009cited by this paper
• HDL Subspecies in Young Adult Twins: Heritability and Impact of Overweight

  2009cited by this paper
• Genotypic Effect of ABCG1 gene promoter -257T>G polymorphism on coronary artery disease severity in Japanese men.

  2009cited by this paper
• Major lipids, apolipoproteins, and risk of vascular disease.

  2009cited by this paper
• The T111I variant in the endothelial lipase gene and risk of coronary heart disease in three independent populations.

  2009cited by this paper
• Functional Lecithin: Cholesterol Acyltransferase Is Not Required for Efficient Atheroprotection in Humans

  2009cited by this paper
• Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts

  2009cited by this paper
• Levels of lipids and apolipoproteins in three cultures.

  2009influential reference
• Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.

  2009cited by this paper
• Lack of Abcg1 results in decreased plasma HDL cholesterol levels and increased biliary cholesterol secretion in mice fed a high cholesterol diet.

  2009cited by this paper
• Influence of apolipoproteinCII concentrations on HDL subclass distribution.

  2009cited by this paper
• Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.

  2008influential reference
• Apolipoprotein CIII and atherosclerosis: beyond effects on lipid metabolism.

  2008cited by this paper
• Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting Published, JLR Papers in Press, January 19, 2008.

  2008cited by this paper
• High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.

  2008cited by this paper
• Heparan sulfate proteoglycans and triglyceride-rich lipoprotein metabolism

  2008cited by this paper
• Genetic variation in phospholipid transfer protein modulates lipoprotein profiles in hyperalphalipoproteinemia.

  2008cited by this paper
• A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection

  2008cited by this paper
• Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A‐V deficiency due to a novel mutation in the APOA5 gene

  2008cited by this paper
• Newly identified loci that influence lipid concentrations and risk of coronary artery disease

  2008cited by this paper
• The value of HDL genetics

  2008cited by this paper
• Low HDL Cholesterol Is a Risk Factor for Deficit and Decline in Memory in Midlife: The Whitehall II Study

  2008cited by this paper
• OSBP-related Protein 8 (ORP8) Suppresses ABCA1 Expression and Cholesterol Efflux from Macrophages*

  2008cited by this paper
• Protective effect of an endothelial lipase gene variant on coronary artery disease in a Chinese population Published, JLR Papers in Press, November 6, 2007.

  2008cited by this paper
• Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans

  2008cited by this paper
• Acute Elevation of Plasma PLTP Activity Strongly Increases Pre-existing Atherosclerosis

  2008cited by this paper
• Effect of Apolipoprotein M on High Density Lipoprotein Metabolism and Atherosclerosis in Low Density Lipoprotein Receptor Knock-out Mice*

  2008cited by this paper

• Bioinformatics Studies on the Association between Obesity Genes and Their Interacting microRNAs with Disease Occurrence

  2025cites this paper
• Loss of GPR146 decreases plasma levels of HDL cholesterol via post-translational upregulation of SR-B1 protein levels.

  2025cites this paper
• Investigation into the molecular mechanisms of biomarkers in psoriasis vulgaris with reduced high-density lipoprotein levels based on bulk transcriptome sequencing data.

  2024cites this paper
• HDL and chronic kidney disease

  2023cites this paper
• A Polynesian-specific missense CETP variant alters the lipid profile

  2023cites this paper
• Hepatic Cdkal1 deletion regulates HDL catabolism and promotes reverse cholesterol transport.

  2023cites this paper
• Rethinking HDL-C: An In-Depth Narrative Review of Its Role in Cardiovascular Health.

  2023cites this paper
• Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis

  2022cites this paper
• High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives

  2021cites this paper
• Large HDL2 combined with inflammatory factors as superior predictors for coronary artery disease than small HDL3

  2021cites this paper
• Caecal microbiota could effectively increase chicken growth performance by regulating fat metabolism

  2021cites this paper
• Pediatric dyslipidemias: lipoprotein metabolism disorders in children

  2021cites this paper
• A population-specific missense variant rs1597000001 in CETP promotes a favorable lipid profile and reduces CETP activity.

  2021cites this paper
• Is a High HDL-Cholesterol Level Always Beneficial?

  2021cites this paper
• Genetics and regulation of HDL metabolism.

  2021cites this paper
• Cecal microbiota affects chicken growth performance by regulating fat metabolism

  2020cites this paper
• High-Density Lipoprotein (HDL) Inhibits Serum Amyloid A (SAA)-Induced Vascular and Renal Dysfunctions in Apolipoprotein E-Deficient Mice

  2020cites this paper
• CETP, LIPC, and SCARB1 variants in individuals with extremely high high-density lipoprotein-cholesterol levels

  2019cites this paper
• Impact of Cholesterol on Ischemic Stroke in Different Human-Like Hamster Models: A New Animal Model for Ischemic Stroke Study

  2019cites this paper
• HDL Cholesterol as a Marker of Disease Severity and Prognosis in Patients with Pulmonary Arterial Hypertension

  2019cites this paper
• Inheritance of high and low HDL: mechanisms and management.

  2019cites this paper
• Genetic risk scores in lipid disorders.

  2019cites this paper
• Paradoxical Hypercholesterolemia in an Otherwise Healthy Adult Man.

  2019cites this paper
• A novel homozygous ABCA1 variant in an asymptomatic man with profound hypoalphalipoproteinemia.

  2018cites this paper
• The acute effects on duodenal gene expression in healthy men following consumption of a low-fat meal enriched with theobromine or fat

  2018cites this paper
• Monogenic diseases in India.

  2018cites this paper
• Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders.

  2018cites this paper
• HDL as a Target for Glycemic Control.

  2017cites this paper
• Therapies Targeting HDLc Levels and HDL Function

  2017cites this paper
• Theobromine: effects on postprandial metabolism, vascular function and intestinal gene expression in humans

  2017cites this paper
• Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency patient-oriented and epidemiological research

  2017cites this paper
• Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview

  2017cites this paper
• Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency[S]

  2017cites this paper
• Update on the molecular biology of dyslipidemias.

  2016cites this paper
• The unresolved mystery of high-density lipoprotein: time for a paradigm shift?

  2016cites this paper
• A loss-of-function variant in OSBPL1A predisposes to low plasma HDL cholesterol levels and impaired cholesterol efflux capacity.

  2016cites this paper
• Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk.

  2016cites this paper
• Ethnicity and coronary artery disease: the role of high-density lipoprotein – a change in paradigm

  2015cites this paper
• HDL and atherosclerosis: Insights from inherited HDL disorders.

  2015cites this paper
• HDL re-examined

  2015cites this paper
• Beyond the genetics of HDL: why is HDL cholesterol inversely related to cardiovascular disease?

  2015cites this paper
• High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk

  2015cites this paper
• Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs

  2015cites this paper
• Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9.

  2015cites this paper
• Novel Therapies Focused on the High-Density Lipoprotein Particle

  2014cites this paper
• HDL and cardiovascular disease.

  2014cites this paper
• ATP-binding cassette transporters, atherosclerosis, and inflammation.

  2014cites this paper
• HDL and cholesterol handling in the brain.

  2014cites this paper
• Genetic determinants of HDL metabolism.

  2014cites this paper
• HDL-targeted therapies: progress, failures and future

  2014cites this paper
• Spotlight on HDL biology: new insights in metabolism, function, and translation.

  2014cites this paper
• A Closer Look at Cardioprotective Function of HDL: Revise the HDL – Cholesterol Hypothesis?

  2014cites this paper
• Regulation of High-Density Lipoprotein Metabolism

  2014cites this paper
• Arteriosclerosis, Thrombosis, and Vascular Biology

  year unknowncites this paper
• Functional Insights Into Novel Regulators of Plasma Lipids

  year unknowncites this paper